Insulin Dosing for Dexamethasone-Induced Hyperglycemia
Start insulin glargine (Lantus) at 14 units once daily in the morning, use an insulin sensitivity factor (ISF) of 1:25 mg/dL, and begin with an insulin-to-carbohydrate ratio (ICR) of 1:10 if the patient resumes eating.
Rationale for Basal Insulin Dose
Given this patient's clinical picture—recent dexamethasone exposure (4 mg twice within 24 hours), persistent hyperglycemia (308-396 mg/dL), low appetite, weight 54.6 kg, and normal renal function—the total daily insulin dose should account for both baseline diabetes needs and steroid-induced insulin resistance.
Calculation approach 1:
- For blood glucose 201-400 mg/dL: 0.5 units/kg/day is the standard starting dose
- 0.5 units/kg × 54.6 kg = 27.3 units total daily dose (TDD)
- However, given recent dexamethasone and the insulin-resistant column recommendation for patients on corticosteroids 1, consider starting at the higher end
For dexamethasone-specific management 2:
- Add 0.1-0.4 units/kg of long-acting insulin (glargine) when dexamethasone is used
- For this patient: 0.25 units/kg × 54.6 kg = 13.7 units (round to 14 units)
- Dexamethasone has prolonged action requiring once or twice-daily basal insulin 3, 2
Distribute as 50% basal, 50% nutritional/correctional 1:
- If using full basal-bolus: 27.3 ÷ 2 = 13.7 units basal (round to 14 units glargine once daily)
- Given low appetite and NPO risk, start with basal insulin alone plus aggressive correctional dosing 1, 4
Timing of Basal Insulin
Give insulin glargine in the morning when dexamethasone was administered 2. Dexamethasone causes disproportionate daytime hyperglycemia with potential normalization overnight 3. Morning dosing of glargine matches the steroid's glycemic effect pattern.
Insulin Sensitivity Factor (ISF)
Use ISF of 1:25 mg/dL (insulin-resistant column) 1:
- Standard formula: 1800 ÷ TDD for rapid-acting insulin
- 1800 ÷ 27 = approximately 1:67 for insulin-sensitive patients
- However, this patient is on corticosteroids, requiring the insulin-resistant correctional scale 1
- The guideline explicitly states: "Start at insulin-resistant column in patients receiving corticosteroids" 1
Correctional Insulin Dosing
Use the insulin-resistant column for all correctional doses 1:
| Blood Glucose (mg/dL) | Rapid-Acting Insulin Units |
|---|---|
| 301-350 | 14 units |
| 351-400 | 16 units |
| ≥400 | 18 units |
- Administer rapid-acting insulin (lispro, aspart, or glulisine) every 4-6 hours if NPO 1
- For current glucose of 308-396 mg/dL: give 14-16 units of rapid-acting insulin now
Insulin-to-Carbohydrate Ratio (ICR)
If patient resumes eating, use ICR of 1:10 5:
- Standard formula: 500 ÷ TDD = 500 ÷ 27 = approximately 1:18 for baseline
- Adjust for steroid-induced resistance: Use more aggressive ratio of 1:10 (1 unit per 10 grams carbohydrate)
- This accounts for the significant insulin resistance from dexamethasone 2
Critical Management Points
Avoid common pitfalls:
- Do NOT use sliding scale insulin alone in this scenario—it leads to 3-fold increased risk of hyperglycemia 1
- Do NOT underdose initially—recent data shows insulin glargine is commonly underdosed for dexamethasone-induced hyperglycemia, leading to reliance on reactive bolus insulin 6
- Monitor for hypoglycemia risk factors: Age <65 years is protective, but low BMI (54.6 kg) and poor oral intake increase risk 7
Jardiance (SGLT2 inhibitor) should remain discontinued during acute illness given nausea, vomiting, and risk of euglycemic DKA, especially with recent anion gap of 16 and bicarbonate of 18 8.
- Increase basal insulin by 10-15% or 2-4 units every 1-2 days based on fasting glucose
- Target fasting glucose 80-130 mg/dL for hospitalized non-critical patients 3, 4
- Adjust correctional insulin doses by 10-20% if hypoglycemia occurs 9
When dexamethasone is discontinued, expect insulin requirements to drop significantly—reduce basal insulin by 30-50% and monitor closely for hypoglycemia 2.